Katrina J. Church - 01 Apr 2022 Form 4/A - Amendment Insider Report for Bioventus Inc. (BVS)

Role
SVP & Chief Compliance Officer
Signature
/s/Anthony D'Adamio, Attorney-in-Fact
Issuer symbol
BVS
Transactions as of
01 Apr 2022
Net transactions value
-$1,007
Form type
4/A - Amendment
Filing time
08 Jun 2023, 20:05:01 UTC
Date Of Original Report
21 Apr 2023
Previous filing
12 Apr 2023
Next filing
05 Apr 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BVS Class A Common Stock Sale $211 -15 -0.14% $14.07 10,338 01 Apr 2022 Direct F1
transaction BVS Class A Common Stock Sale $390 -58 -0.56% $6.73 10,280 01 Jul 2022 Direct F1
transaction BVS Class A Common Stock Sale $406 -58 -0.56% $7.00 10,222 03 Oct 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects shares sold to cover taxes in connection with purchases made under the Company's 2021 Employee Stock Purchase Plan and a Rule 10b5-1 instruction in place at the time of such purchases.

Remarks:

The Form 4/A is being filed to uncheck the Rule 10b5-1(c) Transaction Indication box that was previously inadvertently checked.